Literature DB >> 25353716

Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work?

Robert L Goldenberg1, Bonnie Jones, Jennifer B Griffin, Doris J Rouse, Beena D Kamath-Rayne, Nehal Trivedi, Elizabeth M McClure.   

Abstract

OBJECTIVE: Preeclampsia/eclampsia (PE/E) remains a major cause of maternal death in low-income countries. We evaluated interventions to reduce PE/E-related maternal mortality in sub-Saharan Africa.
DESIGN: Mathematical model to assess impact of interventions on PE/E-related maternal morbidity and mortality.
SETTING: Sub-Saharan Africa countries. POPULATION: Pregnant women in sub-Saharan Africa in 2012.
METHODS: A systematic literature review populated a decision-tree mathematical model with interventions to diagnose, prevent, and treat women with PE/E. The impact of increased use of interventions [diagnostics, transfer to a hospital, magnesium sulfate (MgSO4 ) use, cesarean section/labor induction] on PE/E-related maternal mortality was analyzed. MAIN OUTCOME MEASURES: Prevalence of PE/E and PE/E-associated maternal mortality rates in sub-Saharan Africa.
RESULTS: Without interventions, an estimated 20 570 PE/E-associated deaths would have occurred in sub-Saharan Africa in 2012. With current low rates of diagnosis, MgSO4 use, transfers and cesarean section/induction rates, about 17 520 maternal deaths were associated with PE/E in 2012. Higher use of MgSO4 would have prevented about 610 deaths. With high diagnostic levels, MgSO4 use, transfer and cesarean section/induction, mortality was reduced to 3750 annual deaths, saving about 13 770 maternal lives. If all MgSO4 use was removed from the model, 4060 maternal deaths would occur, increasing maternal deaths by only 310.
CONCLUSIONS: In sub-Saharan Africa, our model suggests that increasing use of PE/E diagnostics, transfer to higher levels of care and increased hospitalization with cesarean section/induction of labor would substantially reduce maternal mortality from PE/E. Increasing use of MgSO4 would have a smaller impact on maternal mortality.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Preeclampsia; eclampsia; magnesium sulfate; maternal mortality; sub-Saharan Africa

Mesh:

Substances:

Year:  2014        PMID: 25353716     DOI: 10.1111/aogs.12533

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  18 in total

1.  Giants in Obstetrics and Gynecology Series: a profile of Robert L. Goldenberg, MD.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2021-09       Impact factor: 10.693

2.  Prevalence of Eclampsia and Its Maternal-Fetal Outcomes at Gandhi Memorial Hospital, Addis Ababa Ethiopia, 2019: Retrospective Study.

Authors:  Addisu Yeshambel Wassie; Walellign Anmut
Journal:  Int J Womens Health       Date:  2021-02-22

3.  Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.

Authors:  Melissa I March; Carl Geahchan; Julia Wenger; Nandini Raghuraman; Anders Berg; Hamish Haddow; Bri Ann Mckeon; Rulx Narcisse; Jean Louis David; Jennifer Scott; Ravi Thadhani; S Ananth Karumanchi; Sarosh Rana
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

4.  Preeclampsia-Eclampsia Adverse Outcomes Reduction: The Preeclampsia-Eclampsia Checklist.

Authors:  Oroma B Nwanodi
Journal:  Healthcare (Basel)       Date:  2016-05-13

5.  The effects of MCH insurance cards on improving equity in access and use of maternal and child health care services in Tanzania: a mixed methods analysis.

Authors:  August Kuwawenaruwa; Gemini Mtei; Jitihada Baraka; Kassimu Tani
Journal:  J Health Popul Nutr       Date:  2016-11-18       Impact factor: 2.000

6.  Pregnancy outcomes in younger and older adolescent mothers with severe preeclampsia.

Authors:  Priscila E Parra-Pingel; Luis A Quisiguiña-Avellán; Luis Hidalgo; Peter Chedraui; Faustino R Pérez-López
Journal:  Adolesc Health Med Ther       Date:  2017-06-06

7.  Improving pregnancy outcomes in low- and middle-income countries.

Authors:  Robert L Goldenberg; Elizabeth M McClure; Sarah Saleem
Journal:  Reprod Health       Date:  2018-06-22       Impact factor: 3.223

8.  Progesterone Receptor (PGR) gene polymorphism is associated with susceptibility to preterm birth.

Authors:  Immaculate Mbongo Langmia; Yamunah Devi Apalasamy; Siti Zawaih Omar; Zahurin Mohamed
Journal:  BMC Med Genet       Date:  2015-08-19       Impact factor: 2.103

9.  Treatment with Magnesium in Pregnancy.

Authors:  Ragnar Rylander
Journal:  AIMS Public Health       Date:  2015-12-10

10.  Assessing multidimensional care coverage for pre-eclampsia in the era of universal health coverage: A pre-post evaluation of the Salud Mesoamérica Initiative.

Authors:  Aruna M Kamath; Casey K Johanns; Maximillian G Thom; Rebecca M Cogen; Diego Rios-Zertuche; Ali H Mokdad; Bernardo Hernández
Journal:  Int J Gynaecol Obstet       Date:  2020-03-25       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.